A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published in the Journal of Clinical...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2C77rki
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other ...
-
Abstract Objectives Our aims were to examine the prevalence and genetic predictors of aspirin and clopidogrel high on-treatment platelet...
-
Mammalian sperm feature a specialized secretory organelle on the anterior part of the sperm nucleus, the acrosome, which is essential for ma...
-
Labor is regarded as increased myometrial activity with a regular contractility pattern. At this final stage of pregnancy, myometrial quiesc...
-
Related Articles Video Nasoendoscopic-Assisted Transoral Adenoidectomy with the PEAK PlasmaBlade: A Preliminary Report of a Case Serie...
-
Abstract Background The small portion of leukemic stem cells (LSCs) in acute myeloid leukemia (AML) present in children and adolescents ...
-
Intraoperative Placement of Paravertebral Catheters to Manage Postoperative Pain in Opioid-Dependent Patients After Thoracolumbar Spine Fusi...
-
Most traditional chemotherapy for cancer has dangerous side effects, but new research is finding ways to develop 'targeted agents' t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου